Nuechterlein Carole
Related Filers (5)
- Aligos Therapeutics, Inc. (6)
- Millendo Therapeutics, Inc. (4)
- Entrada Therapeutics, Inc. (3)
- AveXis, Inc. (2)
- BCTG Acquisition Corp. (1)
- Show More ...
Ownership (16)
4
Friday, 10/27/2023
Aligos Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 7/21/2023
Aligos Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 6/27/2022
Aligos Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 6/6/2022
Entrada Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 11/1/2021
Entrada Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 10/28/2021
Entrada Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Thursday, 6/17/2021
Aligos Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 10/20/2020
Aligos Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 10/15/2020
Aligos Therapeutics, Inc.: Initial statement of beneficial ownership of securities
3
Thursday, 9/3/2020
BCTG Acquisition Corp.: Initial statement of beneficial ownership of securities
4
Tuesday, 6/23/2020
Millendo Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 6/21/2019
Millendo Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 1/17/2019
Millendo Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Tuesday, 12/11/2018
Millendo Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Friday, 2/12/2016
AveXis, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 2/10/2016
AveXis, Inc.: Initial statement of beneficial ownership of securities